v3.25.4
Condensed Consolidated Statements of Cash Flows - USD ($)
 3 Months Ended 6 Months Ended 12 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Mar. 31, 2025
Mar. 31, 2024
CASH USED IN OPERATING ACTIVITIES            
Net income (loss) $ 2,978,000 $ 16,717,000 $ 4,666,000 $ 7,059,000 $ (3,516,000) $ (8,510,000)
Adjustments to reconcile net loss to cash used in operating activities            
Share-based compensation     137,000 894,000 1,767,000 2,894,000
Shares issued for services     681,000
Amortization of intangible assets 269,000 269,000 538,000 538,000 1,076,000 1,076,000
Depreciation 504,000 396,000 1,002,000 562,000 1,552,000 3,000
Excess of fair value of warrants over proceeds of private Placement 659,000 1,040,000
Change in fair value of warrant liabilities (8,848,000) (20,788,000) (14,171,000) (15,521,000) (13,229,000) (2,082,000)
Changes in assets and liabilities:            
Gain/Loss on warrants modification 2,444,000   2,444,000    
Accounts receivable     (132,000) (868,000) (337,000) (76,000)
Inventory     (1,070,000) (1,061,000)
Prepaid expenses     (120,000) 88,000 62,000 143,000
Lease liability     1,000 1,000
Trade payables and other liabilities     (126,000) (717,000) (810,000) (36,000)
Net cash used in operating activities     (5,761,000) (8,376,000) (13,455,000) (5,907,000)
CASH USED IN INVESTING ACTIVITIES            
Purchase of equipment     (359,000) (961,000) (1,328,000) (2,617,000)
Net cash used in investing activities     (359,000) (961,000) (1,328,000) (2,617,000)
CASH PROVIDED BY FINANCING ACTIVITIES            
Proceeds from private placement of shares     5,000,000 16,867,000 24,417,000 9,256,000
Share issuance costs     (194,000) (206,000) (602,000) (300,000)
Subscriptions received for private placement     679,000
Proceeds from exercise of warrants     181,000
Proceeds from exercise of options 0 0 112,000
Net cash provided by financing activities     4,806,000 16,661,000 24,494,000 9,249,000
Net change in cash     (1,314,000) 7,324,000 9,711,000 725,000
Beginning cash balance     10,737,000 1,026,000 1,026,000 301,000
Ending cash balance $ 9,423,000 $ 8,350,000 9,423,000 8,350,000 10,737,000 1,026,000
Supplemental disclosures of non-cash transactions:            
Equipment purchases included in trade payables     2,000 (119,000) 322,000
Excess fair value of warrants over private placements proceeds     659,000    
Shares issued for debt settlement     679,000    
Value of common shares issued as milestone payments       1,005,000 908,000
Private placement proceeds allocated to derivative liabilities     4,647,000    
Private placement proceeds allocated to warrant liability     15,442,000 22,972,000
Accounts receivable settled through share cancellation     75,000    
Share issuance costs for common shares issued     188,000
Share issuance costs settled by issuance of shares     $ 1,005,000